Lande Jerome J.
Known title: DirectorCIK: 0001578266
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
No CNMD-Specific News in Past 7 Days. The only news article in the past week references Henry Schein (HSIC), not CONMED itself. This appears to be a sector comparison piece tracking HSIC's performance since its last earnings release. There is no recent CNMD-specific news to report. Market participants seeking updates on CONMED's operations, financial results, or strategic developments will need to look beyond this seven-day window.
Transaction History
| ITRI | ▲ Buy | Grant | 608 | $0 | 10/1/2026 | View on chart |
| ITRI | ▲ Buy | Grant | 621 | $0 | 7/1/2026 | View on chart |
| ITRI | ▲ Buy | Grant | 580 | $0 | 4/1/2026 | View on chart |
| ITRI | ▲ Buy | Grant | 529 | $0 | 1/2/2026 | View on chart |
| ITRI | ▲ Buy | Grant | 408 | $0 | 10/1/2025 | View on chart |
| ITRI | ▲ Buy | Grant | 377 | $0 | 7/1/2025 | View on chart |
| ITRI | ▲ Buy | Grant | 472 | $0 | 4/1/2025 | View on chart |
| ITRI | ▲ Buy | Grant | 460 | $0 | 1/2/2025 | View on chart |
| ITRI | ▲ Buy | Grant | 475 | $0 | 10/1/2024 | View on chart |
| ITRI | ▲ Buy | Grant | 509 | $0 | 7/1/2024 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 302 | $0 | 5/31/2024 | View on chart |
| ITRI | ▲ Buy | Grant | 558 | $0 | 4/1/2024 | View on chart |
| ITRI | ▼ Sell | Open Market | 5,720 | $546K | 3/7/2024 | View on chart |
| ITRI | ▼ Sell | Open Market | 3,169 | $300K | 3/7/2024 | View on chart |
| ITRI | ▼ Sell | Open Market | 6,007 | $573K | 3/7/2024 | View on chart |
| ITRI | ▲ Buy | Grant | 665 | $0 | 1/2/2024 | View on chart |
| ITRI | ▲ Buy | Grant | 701 | $0 | 10/2/2023 | View on chart |
| ITRI | ▲ Buy | Grant | 578 | $0 | 7/3/2023 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 335 | $0 | 6/1/2023 | View on chart |
| ITRI | ▲ Buy | Grant | 745 | $0 | 4/3/2023 | View on chart |
| ITRI | ▲ Buy | Grant | 797 | $0 | 1/3/2023 | View on chart |
| ITRI | ▲ Buy | Grant | 937 | $41K | 10/3/2022 | View on chart |
| ITRI | ▲ Buy | Grant | 851 | $41K | 7/1/2022 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 812 | $0 | 6/1/2022 | View on chart |
| CNMD | ▼ Sell | Open Market | 1,521 | $178K | 5/17/2022 | View on chart |
| CNMD | ▼ Sell | Open Market | 6,000 | $693K | 5/13/2022 | View on chart |
| ITRI | ▲ Buy | Grant | 774 | $0 | 4/1/2022 | View on chart |
| ITRI | ▲ Buy | Grant | 598 | $0 | 1/3/2022 | View on chart |
| ITRI | ▲ Buy | Grant | 424 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Itron Launches New Grid Reliability Solution
Itron introduced a new feeder reliability solution designed to help utilities improve grid stability without expensive infrastructure upgrades. This product launch supports the company's strategy to monetize smart meter data and may address concerns about its investment narrative. The stock is currently trading near its 52-week low, with analysts maintaining a significantly higher average price target.
Itron Launches New Grid Reliability Solution. Itron introduced a new feeder reliability solution designed to help utilities improve grid stability without expensive infrastructure upgrades. This product launch supports the company's strategy to monetize smart meter data and may address concerns about its investment narrative. The stock is currently trading near its 52-week low, with analysts maintaining a significantly higher average price target.